Insider Trading History of Hayden Donald J Jr

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Hayden Donald J Jr since 2011. This trader's CIK number is 1202285. At the time of last reporting, Hayden Donald J Jr was the Officer of Theseus Pharmaceuticals, Inc.. (stock ticker symbol THRX). Also see all insider trading activities at Theseus Pharmaceuticals, Inc..

Note that in the past HAYDEN DONALD J JR also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Vitae Pharmaceuticals, Inc (VTAE) by Hayden Donald J Jr

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2016 VTAE 0 $0 16,130 $119,684 16,130 $55,648
2015 VTAE 0 $0 52,260 $804,750 52,260 $180,296

Yearly summary of insider trading at Regenxbio Inc. (RGNX) by Hayden Donald J Jr

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 RGNX 0 $0 60,000 $2,870,760 60,000 $51,000
2018 RGNX 0 $0 45,000 $2,250,945 45,000 $38,249
2017 RGNX 0 $0 158,599 $4,208,574 120,000 $102,000

Yearly summary of insider trading at Theseus Pharmaceuticals, Inc. (THRX) by Hayden Donald J Jr

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 THRX 10,000 $49,990 0 $0 0 $0

Yearly summary of insider trading at Insmed Inc (INSM) by Hayden Donald J Jr

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 INSM 0 $0 6,386 $210,165 6,386 $19,349
2017 INSM 0 $0 60,000 $1,822,500 60,000 $181,800
2015 INSM 0 $0 25,000 $601,448 0 $0
2014 INSM 0 $0 0 $0 8,955 $0
2013 INSM 0 $0 0 $0 15,988 $0
2012 INSM 0 $0 0 $0 8,594 $0
2011 INSM 12,937 $69,648 0 $0 0 $0

Yearly summary of insider trading at Amicus Therapeutics, Inc. (FOLD) by Hayden Donald J Jr

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 FOLD 0 $0 20,000 $300,000 20,000 $300,000
2015 FOLD 0 $0 55,000 $770,385 55,000 $770,385


Insider trading activities at 5 companies by Hayden Donald J Jr:

1. Vitae Pharmaceuticals, Inc (VTAE)

2. Regenxbio Inc. (RGNX)

3. Theseus Pharmaceuticals, Inc. (THRX)

4. Insmed Inc (INSM)

5. Amicus Therapeutics, Inc. (FOLD)

Table 1. Insider trading of Vitae Pharmaceuticals, Inc (VTAE) by Hayden Donald J Jr

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2016-03-21 VTAE Sale 16,130 7.42 119,684
2016-03-21 VTAE Option Ex 16,130 3.45 55,648
2015-12-29 VTAE Option Ex 16,130 3.45 55,648
2015-12-29 VTAE Sale 16,130 18.00 290,340
2015-09-21 VTAE Option Ex 16,130 3.45 55,648
2015-09-21 VTAE Sale 16,130 17.00 274,210
2015-05-20 VTAE Option Ex 20,000 3.45 69,000
2015-05-20 VTAE Sale 20,000 12.01 240,200

Table 2. Insider trading of Regenxbio Inc. (RGNX) by Hayden Donald J Jr

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-02-10 RGNX Option Ex 24,800 .85 21,080
2020-02-10 RGNX Sale 24,800 50.11 1,242,728
2020-02-05 RGNX Option Ex 2,000 .85 1,700
2020-02-05 RGNX Sale 2,000 50.00 100,000
2020-01-17 RGNX Option Ex 3,200 .85 2,720
2020-01-17 RGNX Sale 3,200 50.01 160,032
2020-01-14 RGNX Option Ex 30,000 .85 25,500
2020-01-14 RGNX Sale 30,000 45.60 1,368,000
2018-06-01 RGNX Option Ex 100 .85 85
2018-06-05 RGNX Sale 14,900 55.01 819,649
2018-06-05 RGNX Option Ex 14,900 .85 12,665
2018-06-01 RGNX Sale 100 55.00 5,500
2018-05-15 RGNX Sale 9,847 50.06 492,940
2018-05-14 RGNX Option Ex 5,153 .85 4,380
2018-05-15 RGNX Option Ex 9,847 .85 8,369
2018-05-14 RGNX Sale 5,153 50.04 257,856
2018-05-09 RGNX Option Ex 15,000 .85 12,750
2018-05-09 RGNX Sale 15,000 45.00 675,000
2017-10-11 RGNX Sale 20,000 34.95 699,000
2017-10-11 RGNX Option Ex 20,000 .85 17,000
2017-09-27 RGNX Option Ex 20,000 .85 17,000
2017-09-27 RGNX Sale 20,000 32.45 649,000
2017-09-15 RGNX Option Ex 20,000 .85 17,000
2017-09-15 RGNX Sale 20,000 27.45 549,000
2017-09-18 RGNX Option Ex 20,000 .85 17,000
2017-09-18 RGNX Sale 20,000 29.95 599,000
2017-09-05 RGNX Sale 20,000 24.95 499,000
2017-09-05 RGNX Option Ex 20,000 .85 17,000
2017-05-15 RGNX Sale 8,599 19.04 163,724
2017-05-08 RGNX Sale 10,000 18.35 183,500
2017-05-01 RGNX Option Ex 20,000 .85 17,000
2017-05-01 RGNX Sale 30,000 21.89 656,550
2017-04-24 RGNX Sale 10,000 20.98 209,800

Table 3. Insider trading of Theseus Pharmaceuticals, Inc. (THRX) by Hayden Donald J Jr

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-12-29 THRX Buy 100 5.00 500
2022-12-30 THRX Buy 9,900 5.00 49,490

Table 4. Insider trading of Insmed Inc (INSM) by Hayden Donald J Jr

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-04-09 INSM Sale 6,286 32.99 207,375
2019-04-09 INSM Option Ex 6,286 3.03 19,046
2019-02-15 INSM Sale 100 27.90 2,790
2019-02-15 INSM Option Ex 100 3.03 303
2017-11-14 INSM Option Ex 15,000 3.03 45,450
2017-11-14 INSM Sale 15,000 32.50 487,500
2017-09-07 INSM Sale 15,000 30.00 450,000
2017-09-07 INSM Option Ex 15,000 3.03 45,450
2017-09-05 INSM Sale 30,000 29.50 885,000
2017-09-05 INSM Option Ex 30,000 3.03 90,900
2015-09-01 INSM Sale 15,748 24.05 378,707
2015-09-02 INSM Sale 9,252 24.07 222,741
2014-01-11 INSM Option Ex 8,955 .00 0
2013-01-14 INSM Option Ex 15,988 .00 0
2012-01-23 INSM Option Ex 8,594 .00 0
2011-03-29 INSM Buy 2,200 6.36 13,992
2011-03-24 INSM Buy 9,400 5.15 48,410
2011-03-25 INSM Buy 1,337 5.42 7,246

Table 5. Insider trading of Amicus Therapeutics, Inc. (FOLD) by Hayden Donald J Jr

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-01-02 FOLD Sale 20,000 15.00 300,000
2018-01-02 FOLD Option Ex 20,000 15.00 300,000
2015-06-23 FOLD Sale 55,000 14.01 770,385
2015-06-23 FOLD Option Ex 55,000 14.01 770,385

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hayden Donald J Jr (Officer of Theseus Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.